New eye implant aims to keep glaucoma in check
Disease control
Ongoing
This study tests a new surgical implant, the VividWhite Glaucoma Implant, in 65 people with glaucoma. The goal is to see if it safely lowers eye pressure and reduces the need for eye drops. The implant is designed to help control the disease, not cure it.
Phase: NA • Sponsor: VividWhite Pty Ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC